Retatrutide as a triple agonist — what the trial literature says

Sharing notes from publicly reported trial summaries on retatrutide's triple-agonist mechanism (GLP-1 / GIP / glucagon receptors). Purely mechanism and published-results discussion.

What stands out is how early the public data still is compared to the older analogs. Anyone tracking the peer-reviewed write-ups want to compare reference lists? I'd rather cite primary sources than secondhand summaries.

Agree the public data is early. The glucagon-receptor arm is the part I'd flag as least settled in the literature — worth reading the mechanism papers before any secondhand summary. I'll dig out citations for the index.

Seconding "primary sources over summaries." Half the confident claims online about this compound trace back to a single conference abstract. Cite the peer-reviewed write-up or caveat it.

Want to join the discussion?

Related discussions

Reading a Tirzepatide COA — identity vs purity for a dual agonist

Semaglutide vs Tirzepatide: the receptor-pathway difference, plainly

Assay reference for GLP-1 analog identity — anyone have one?

Keeping GLP-1 threads on the research side of the line

Appetite-signalling literature swap (GLP-1 mechanism reading)

PRECISION. PURITY. PERFORMANCE.

Research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical & Freedom Diagnostics, with Certificates of Analysis published per released batch. Supplied strictly for laboratory research use.

Shop

All research compounds

Price list

Where to buy peptides

Research